Effect of DPP4 Inhibition on Vasoconstriction

NCT02639637 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

18

Enrollment

OTHER

Sponsor class

Conditions

Type 2 Diabetes Mellitus

Interventions

DRUG: Sitagliptin
DRUG: Placebo
DRUG: Neuropeptide Y
DRUG: Enalaprilat
DRUG: Valsartan 160mg

Sponsor

Vanderbilt University